FORT MYERS, Fla., Feb. 7, 2014 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc. ("21st Century Oncology" or "the Company"), the largest global, physician led provider of integrated cancer care services, announced today the promotion of Bryan J. Carey to President, in addition to his continuing responsibilities as Chief Financial Officer.
Dr. Daniel Dosoretz, Founder and Chief Executive Officer, commented, "Bryan has been instrumental in driving our operational, development and financial initiatives as CFO. This additional title more accurately represents the broader value he has delivered in streamlining our ICC strategy, executing and integrating major acquisitions and driving daily operations. We are currently operating in the most exciting time in our Company's history, and I look forward to a continued, close working relationship with Bryan as we work together to leverage our leading integrated cancer care platform to drive sustainable growth over the next several years."
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. (Formerly Radiation Therapy Services Holdings, Inc.) is the largest global, physician led provider of Integrated Cancer Care Services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2013, the Company operated 163 treatment centers, including 130 centers located in 16 U.S. states. The Company also operated 33 centers located in six countries in Latin America. The Company holds market leading positions in most of its domestic local markets and abroad.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words "believes", "expects", "anticipates", "intends", "projects", "estimates", "plans", "may increase", "forecast" and similar expressions or future or conditional verbs such as "will", "should", "would", "may" and "could" are generally forward-looking in nature and not historical facts. Forward-looking statements are based on management's current expectations or beliefs about the Company's future plans, expectations and objectives, including, but not limited to, the Company's expected financial results and estimates for 2014 and the effects of the CMS's Final Rule for the 2013 Physician Fee Schedule on its results. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to reductions in Medicare reimbursement, healthcare reform, decreases in payments by managed care organizations and other commercial payers and other risk factors that may be described from time to time in the Company's filings with the Securities and Exchange Commission. Readers of this release are cautioned not to place undue reliance on forward-looking statements contained herein, which speak only as of the date stated, or if no date is stated, as of the date of this press release. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release, unless required by law.
CONTACT: Bryan J. Carey President and Chief Financial Officer 239-931-7285 BCarey@rtsx.com Investors: Nick Laudico The Ruth Group 646-536-7030 email@example.comSource: 21stCentury Oncology Holdings, Inc.